Vaccines, blood, antisera, toxins and cultures in   Malawi

Exports In 2018, Malawi exported $90.9k in Vaccines, blood, antisera, toxins and cultures, making it the 131st largest exporter of Vaccines, blood, antisera, toxins and cultures in the world. At the same year, Vaccines, blood, antisera, toxins and cultures was the 153rd most exported product in Malawi. The main destination of Vaccines, blood, antisera, toxins and cultures exports from Malawi are: Rwanda ($60.6k), Kenya ($11.9k), Tanzania ($10.7k), United States ($3.75k), and South Africa ($2.96k).

The fastest growing export markets for Vaccines, blood, antisera, toxins and cultures of Malawi between 2021 and 2022 were Rwanda ($49.6k), Kenya ($10.8k), and United States ($3.75k).

Imports In 2022, Malawi imported $44.4M in Vaccines, blood, antisera, toxins and cultures, becoming the 128th largest importer of Vaccines, blood, antisera, toxins and cultures in the world. At the same year, Vaccines, blood, antisera, toxins and cultures was the 6th most imported product in Malawi. Malawi imports Vaccines, blood, antisera, toxins and cultures primarily from: Belgium ($10.9M), South Korea ($8.02M), Japan ($6.98M), United States ($5.31M), and India ($4.71M).

The fastest growing import markets in Vaccines, blood, antisera, toxins and cultures for Malawi between 2021 and 2022 were Japan ($6.07M), South Africa ($1.14M), and China ($362k).